Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
145K
-
Shares change
-
+65.9K
-
Total reported value, excl. options
-
$108K
-
Value change
-
+$49K
-
Number of buys
-
1
-
Price
-
$0.74
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q4 2023
1 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 145K shares
of 54.8M outstanding shares and own 0.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.55M shares), VANGUARD GROUP INC (2.63M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.81M shares), Chescapmanager LLC (1.75M shares), FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), STATE STREET CORP (1.02M shares), GEODE CAPITAL MANAGEMENT, LLC (1.01M shares), FEDERATED HERMES, INC. (832K shares), AQR CAPITAL MANAGEMENT LLC (829K shares), and RENAISSANCE TECHNOLOGIES LLC (697K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.